title: Timing of Linkage to Care After HIV Diagnosis and Time to Viral Suppression.
authors.affiliation: *Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA †Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
authors.forename: H Irene
authors.initials: HI
authors.lastname: Hall
authors.forename: Tian
authors.initials: T
authors.lastname: Tang
authors.forename: Anna S
authors.initials: AS
authors.lastname: Johnson
authors.forename: Lorena
authors.initials: L
authors.lastname: Espinoza
authors.forename: Norma
authors.initials: N
authors.lastname: Harris
authors.forename: Eugene
authors.initials: E
authors.lastname: McCray
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D005006:Ethnicity; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D061665:Time-to-Treatment; D014481:United States; D019562:Viral Load / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents